These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29858738)

  • 1. Vaccine Adjuvant Incorporation Strategy Dictates Peptide Amphiphile Micelle Immunostimulatory Capacity.
    Zhang R; Kramer JS; Smith JD; Allen BN; Leeper CN; Li X; Morton LD; Gallazzi F; Ulery BD
    AAPS J; 2018 Jun; 20(4):73. PubMed ID: 29858738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide Amphiphile Micelles for Vaccine Delivery.
    Barrett JC; Tirrell MV
    Methods Mol Biol; 2018; 1798():277-292. PubMed ID: 29868967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational Design of Antigen Incorporation Into Subunit Vaccine Biomaterials Can Enhance Antigen-Specific Immune Responses.
    Tsoras AN; Wong KM; Paravastu AK; Champion JA
    Front Immunol; 2020; 11():1547. PubMed ID: 32849524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modern subunit vaccines: development, components, and research opportunities.
    Moyle PM; Toth I
    ChemMedChem; 2013 Mar; 8(3):360-76. PubMed ID: 23316023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide Amphiphile Micelle Vaccine Size and Charge Influence the Host Antibody Response.
    Zhang R; Smith JD; Allen BN; Kramer JS; Schauflinger M; Ulery BD
    ACS Biomater Sci Eng; 2018 Jul; 4(7):2463-2472. PubMed ID: 33435110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide amphiphile micelles self-adjuvant group A streptococcal vaccination.
    Trent A; Ulery BD; Black MJ; Barrett JC; Liang S; Kostenko Y; David NA; Tirrell MV
    AAPS J; 2015 Mar; 17(2):380-8. PubMed ID: 25527256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of adaptive immune response by self-aggregating peptides.
    Zepeda-Cervantes J; Vaca L
    Expert Rev Vaccines; 2018 Aug; 17(8):723-738. PubMed ID: 30074424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant Delivery Method and Nanoparticle Charge Influence Peptide Amphiphile Micelle Vaccine Bioactivity.
    Zhang R; Rygelski BT; Kruse LE; Smith JD; Wang X; Allen BN; Kramer JS; Seim GF; Faulkner TJ; Kuang H; Kokkoli E; Schrum AG; Ulery BD
    bioRxiv; 2024 Oct; ():. PubMed ID: 38915689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subunit vaccines of the future: the need for safe, customized and optimized particulate delivery systems.
    Foged C
    Ther Deliv; 2011 Aug; 2(8):1057-77. PubMed ID: 22826868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing cellular immunogenicity to peptide-based vaccine candidates using a fluorocarbon antigen delivery system.
    Francis JN; Thaburet JF; Bonnet D; Sizer PJ; Brown CB; Georges B
    Vaccine; 2015 Feb; 33(8):1071-6. PubMed ID: 25573036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidized Carbon Nanosphere-Based Subunit Vaccine Delivery System Elicited Robust Th1 and Cytotoxic T Cell Responses.
    Sawutdeechaikul P; Cia F; Bancroft G; Wanichwecharungruang S; Sittplangkoon C; Palaga T
    J Microbiol Biotechnol; 2019 Mar; 29(3):489-499. PubMed ID: 30691253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein.
    Olive C; Sun HK; Ho MF; Dyer J; Horváth A; Toth I; Good MF
    J Infect Dis; 2006 Aug; 194(3):316-24. PubMed ID: 16826479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IC31 and IC30, novel types of vaccine adjuvant based on peptide delivery systems.
    Lingnau K; Riedl K; von Gabain A
    Expert Rev Vaccines; 2007 Oct; 6(5):741-6. PubMed ID: 17931154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Interleukin 12 Adjuvanted Herpes Simplex Virus 2 DNA Vaccine Is More Protective Than a Glycoprotein D Subunit Vaccine in a High-Dose Murine Challenge Model.
    Bagley KC; Schwartz JA; Andersen H; Eldridge JH; Xu R; Ota-Setlik A; Geltz JJ; Halford WP; Fouts TR
    Viral Immunol; 2017 Apr; 30(3):178-195. PubMed ID: 28085634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
    Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
    Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens.
    Swaminathan G; Thoryk EA; Cox KS; Meschino S; Dubey SA; Vora KA; Celano R; Gindy M; Casimiro DR; Bett AJ
    Vaccine; 2016 Jan; 34(1):110-9. PubMed ID: 26555351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subunit-based mucosal vaccine delivery systems for pulmonary delivery - Are they feasible?
    Marasini N; Kaminskas LM
    Drug Dev Ind Pharm; 2019 Jun; 45(6):882-894. PubMed ID: 30767591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress in adjuvant discovery for peptide-based subunit vaccines.
    Azmi F; Ahmad Fuaad AA; Skwarczynski M; Toth I
    Hum Vaccin Immunother; 2014; 10(3):778-96. PubMed ID: 24300669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity.
    Silva AL; Soema PC; Slütter B; Ossendorp F; Jiskoot W
    Hum Vaccin Immunother; 2016 Apr; 12(4):1056-69. PubMed ID: 26752261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.
    Sabhnani L; Manocha M; Sridevi K; Shashikiran D; Rayanade R; Rao DN
    FEMS Immunol Med Microbiol; 2003 Oct; 38(3):215-29. PubMed ID: 14522457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.